Cargando…
Benefits of omalizumab on anxiety and depression in patients with severe asthma
BACKGROUND: Asthma is one of the most common chronic diseases and may cause psychiatric disorders affecting the patients’ quality of life. In our study, we evaluated the effect of omalizumab treatment on anxiety disorder and depression using Beck Depression Scale (BDS) and State Trait Anxiety Invent...
Autores principales: | Uzer, Fatih, Ozbudak, Omer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121347/ https://www.ncbi.nlm.nih.gov/pubmed/30197766 http://dx.doi.org/10.22088/cjim.9.3.228 |
Ejemplares similares
-
Are 25(OH) D concentrations associated with asthma control and pulmonary function test?
por: Uzer, Fatih, et al.
Publicado: (2019) -
The Importance and Place of Methemoglobin and Carboxyhemoglobin Levels in the Diagnosis and Prognosis of Pulmonary Embolism
por: Uzer, Fatih, et al.
Publicado: (2019) -
The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma
por: Chapman, Kenneth R., et al.
Publicado: (2019) -
Long-term benefits of omalizumab in a patient with severe non-allergic asthma
por: Menzella, Francesco, et al.
Publicado: (2011) -
Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)